![JPM | Free Full-Text | Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma JPM | Free Full-Text | Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma](https://www.mdpi.com/jpm/jpm-11-01324/article_deploy/html/images/jpm-11-01324-g001.png)
JPM | Free Full-Text | Tumor Inflammation, Obesity, and Proliferative Status as Biomarkers in Gastroesophageal Adenocarcinoma
![Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species | Drug Metabolism & Disposition Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species | Drug Metabolism & Disposition](https://dmd.aspetjournals.org/sites/default/files/highwire/dmd/50/3.cover-source.jpg)
Comparison of Tissue Abundance of Non-Cytochrome P450 Drug-Metabolizing Enzymes by Quantitative Proteomics between Humans and Laboratory Animal Species | Drug Metabolism & Disposition
![Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response - Rawding - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response - Rawding - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library](https://wires.onlinelibrary.wiley.com/cms/asset/3d2f75da-98eb-4314-a642-aedda9742051/wnan1752-toc-0001-m.jpg)
Dendrimers for cancer immunotherapy: Avidity‐based drug delivery vehicles for effective anti‐tumor immune response - Rawding - 2022 - WIREs Nanomedicine and Nanobiotechnology - Wiley Online Library
![Current Oncology | Free Full-Text | New Strategies and Combinations to Improve Outcomes in Immunotherapy in Metastatic Non-Small-Cell Lung Cancer Current Oncology | Free Full-Text | New Strategies and Combinations to Improve Outcomes in Immunotherapy in Metastatic Non-Small-Cell Lung Cancer](https://www.mdpi.com/curroncol/curroncol-29-00004/article_deploy/html/images/curroncol-29-00004-g001.png)
Current Oncology | Free Full-Text | New Strategies and Combinations to Improve Outcomes in Immunotherapy in Metastatic Non-Small-Cell Lung Cancer
![Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion–Positive, Estrogen Receptor–Positive Breast Cancer After ... Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion–Positive, Estrogen Receptor–Positive Breast Cancer After ...](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/po/2022/po.2022.6/po.21.00446/20220812/images/keyimage.jpg)
Sustained Tumor Regression With Zenocutuzumab, a Bispecific Antibody Targeting Human Epidermal Growth Factor Receptor 2/Human Epidermal Growth Factor Receptor 3 Signaling, in NRG1 Fusion–Positive, Estrogen Receptor–Positive Breast Cancer After ...
![Biomolecules | Free Full-Text | Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma Biomolecules | Free Full-Text | Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma](https://www.mdpi.com/biomolecules/biomolecules-12-01562/article_deploy/html/images/biomolecules-12-01562-g001.png)
Biomolecules | Free Full-Text | Immune Checkpoint Inhibitors and RAS–ERK Pathway-Targeted Drugs as Combined Therapy for the Treatment of Melanoma
Efficient and Selective Uptake of TcO4– by a Cationic Metal–Organic Framework Material with Open Ag+ Sites | Environmental Science & Technology
![JCM | Free Full-Text | Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer JCM | Free Full-Text | Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer](https://www.mdpi.com/jcm/jcm-11-03245/article_deploy/html/images/jcm-11-03245-g001.png)
JCM | Free Full-Text | Blood Biomarkers of Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
![Frontiers | Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments Frontiers | Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments](https://www.frontiersin.org/files/Articles/912699/fonc-12-912699-HTML/image_m/fonc-12-912699-g001.jpg)
Frontiers | Neoadjuvant Treatment in Muscle-Invasive Bladder Cancer: From the Beginning to the Latest Developments
Pyrazolate-Based Porphyrinic Metal–Organic Framework with Extraordinary Base-Resistance | Journal of the American Chemical Society
![Pharmaceutics | Free Full-Text | FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis Pharmaceutics | Free Full-Text | FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-02538/article_deploy/html/images/pharmaceutics-14-02538-g001.png)
Pharmaceutics | Free Full-Text | FDA-Approved Small Molecules in 2022: Clinical Uses and Their Synthesis
![Activists Protest at Whitney Museum, Demanding Vice Chairman and Owner of Tear Gas Manufacturer “Must Go” Activists Protest at Whitney Museum, Demanding Vice Chairman and Owner of Tear Gas Manufacturer “Must Go”](https://i0.wp.com/hyperallergic-newspack.s3.amazonaws.com/uploads/2018/12/Ash-Whitney-Museum-1-720x540.jpg?resize=720%2C540&quality=100&ssl=1)
Activists Protest at Whitney Museum, Demanding Vice Chairman and Owner of Tear Gas Manufacturer “Must Go”
![Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing | British Journal of Cancer Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-022-01908-1/MediaObjects/41416_2022_1908_Fig1_HTML.png)
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testing | British Journal of Cancer
![Frontiers | The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer – New Combinational Approaches and Strategies of Neovessel Inhibition Frontiers | The Role of Anti-angiogenesis in the Treatment Landscape of Non-small Cell Lung Cancer – New Combinational Approaches and Strategies of Neovessel Inhibition](https://www.frontiersin.org/files/Articles/610903/fcell-08-610903-HTML/image_m/fcell-08-610903-g001.jpg)